SP

Swapna Panuganti

Vice President, Cell Therapy Development and Manufacturing at Adicet Bio

Swapna Panuganti has a diverse work experience spanning over several years. Since 2019, they have been working at Adicet Bio, Inc, where they currently hold the position of Vice President of Cell Therapy Development and Manufacturing. Prior to this role, they served as a Senior Director and Director in the same company, handling Cell Therapy Manufacturing Operations.

Before joining Adicet Bio, Inc, Swapna worked at Cellerant Therapeutics from 2011 to 2019. Their roles there include Associate Director of Product Development, Senior Scientist in Process Development, and Scientist in Process Development.

Their earlier experiences include an internship at BioMarin in 2010, where they worked as a Scientist. Swapna also had an intern role at Cetek Corporation in 2005, where they were involved in designing and conducting experiments related to Streptomyces growth and product formation in bioreactors.

During their time at MIT, Swapna worked as an Undergraduate Teaching Assistant from 2004 to 2005. Swapna also held research assistant roles at the Bioprocessing Technology Institute and in the Chemical Engineering departments, working with Professor Danial I.C. Wang, Professor William Deen, and Professor Charles Cooney, respectively.

Overall, Swapna Panuganti has extensive experience in cell therapy development, manufacturing operations, product development, and process development throughout their career.

Swapna Panuganti attended the Massachusetts Institute of Technology from 2001 to 2005, where they obtained a Bachelor of Science degree in Chemical Engineering and Biology. Swapna then pursued their education further at Northwestern University from 2005 to 2011, earning a PhD in Chemical and Biological Engineering.

Links

Previous companies

MIT logo

Org chart

Peers

Timeline

  • Vice President, Cell Therapy Development and Manufacturing

    February, 2022 - present

  • Senior Director, Cell Therapy Manufacturing Operations

    August, 2020

  • Director, Cell Therapy Manufacturing Operations

    December, 2019

View in org chart